Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY, Brent GA: Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells. In: J. Endocrinol. 199. Jahrgang, Nr.2, November 2008, S.243–52, doi:10.1677/JOE-08-0333, PMID 18762555.
Hingorani M, White CL, Zaidi S, et al: Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy. In: Clin. Cancer Res. 14. Jahrgang, Nr.15, August 2008, S.4915–24, doi:10.1158/1078-0432.CCR-07-4049, PMID 18676766.
Tran N, Valentín-Blasini L, Blount BC, et al: Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells. In: Am. J. Physiol. Endocrinol. Metab. 294. Jahrgang, Nr.4, April 2008, S.E802–6, doi:10.1152/ajpendo.00013.2008, PMID 18303123.
Terrovitis J, Kwok KF, Lautamäki R, et al: Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. In: J. Am. Coll. Cardiol. 52. Jahrgang, Nr.20, November 2008, S.1652–60, doi:10.1016/j.jacc.2008.06.051, PMID 18992656.
Willhauck MJ, Samani BR, Wolf I, et al: The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. In: Eur. J. Nucl. Med. Mol. Imaging. 35. Jahrgang, Nr.7, Juli 2008, S.1272–81, doi:10.1007/s00259-008-0775-4, PMID 18404268.
elsevier.com
linkinghub.elsevier.com
Dadachova E, Carrasco N: The Na/I symporter (NIS): imaging and therapeutic applications. In: Semin Nucl Med. 34. Jahrgang, Nr.1, Januar 2004, S.23–31, PMID 14735456 (elsevier.com).
nih.gov
ncbi.nlm.nih.gov
Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY, Brent GA: Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells. In: J. Endocrinol. 199. Jahrgang, Nr.2, November 2008, S.243–52, doi:10.1677/JOE-08-0333, PMID 18762555.
Hingorani M, White CL, Zaidi S, et al: Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy. In: Clin. Cancer Res. 14. Jahrgang, Nr.15, August 2008, S.4915–24, doi:10.1158/1078-0432.CCR-07-4049, PMID 18676766.
Tran N, Valentín-Blasini L, Blount BC, et al: Thyroid-stimulating hormone increases active transport of perchlorate into thyroid cells. In: Am. J. Physiol. Endocrinol. Metab. 294. Jahrgang, Nr.4, April 2008, S.E802–6, doi:10.1152/ajpendo.00013.2008, PMID 18303123.
Terrovitis J, Kwok KF, Lautamäki R, et al: Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. In: J. Am. Coll. Cardiol. 52. Jahrgang, Nr.20, November 2008, S.1652–60, doi:10.1016/j.jacc.2008.06.051, PMID 18992656.
Dadachova E, Carrasco N: The Na/I symporter (NIS): imaging and therapeutic applications. In: Semin Nucl Med. 34. Jahrgang, Nr.1, Januar 2004, S.23–31, PMID 14735456 (elsevier.com).
Willhauck MJ, Samani BR, Wolf I, et al: The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. In: Eur. J. Nucl. Med. Mol. Imaging. 35. Jahrgang, Nr.7, Juli 2008, S.1272–81, doi:10.1007/s00259-008-0775-4, PMID 18404268.